Franklin Biolabs, a contract research organisation (CRO) focused on genetic medicines, has announced the appointment of Dr. Vatsala Naageshwaran as its new Chief Executive Officer. Dr. Naageshwaran brings over two decades of experience in the biopharmaceutical industry, having held leadership
Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company, along with its parent company Shin Nippon Biomedical Laboratories, Ltd. (SNBL), a contract research organization has confirmed that the U.S. Food and Drug Administration (FDA) has accepted its resubmitted New Drug Application (NDA)
Metrion Biosciences, a specialist preclinical contract research organisation (CRO), has appointed Lee Patterson as its new CEO. Effective from 2nd December 2024, Patterson brings a wealth of experience in the life sciences and CRO sectors to the role, succeeding Dr
BioPharmaSpec, a Contract Research Organization (CRO) specialising in the discovery and preclinical characterization of biopharmaceuticals, has announced the opening of three new European facilities. The sites, located in Freiburg, Bergamo, and Vilnius, will support the company’s growing global client base
Reverb Therapeutics has announced a collaboration with Montreal-based Royalmount Laboratories to support pre-IND enabling work on Reverb’s lead drug candidate, which is currently moving towards lead selection. The partnership will focus on critical bioanalytical and development tasks to prepare for
Novotech, a global clinical Contract Research Organization (CRO), has been honoured with multiple awards in the 2024 Clinical Trials Arena Excellence Awards. The awards recognise achievements in Business Expansion, Innovation, and Marketing, underlining the company’s strategic growth and technological advancements
Concept Life Sciences (CLS), a UK-based organisation specialising in drug discovery, development, and manufacturing, has announced the acquisition of Loughborough-based Charnwood Discovery. Supported by Limerston Capital, this acquisition aims to reinforce CLS’s position in the global pharmaceutical and life sciences
Resolian, a global bioanalytical contract research organization (CRO), has announced significant leadership changes to support its expansion and operational capabilities. Rob Stachlewitz has been appointed as the new Chief Executive Officer (CEO), effective immediately. He succeeds Pat Bennett, who will
Alimentiv, a full-service contract research organisation (CRO) focused on gastrointestinal (GI) diseases, has announced the expansion of its collaboration with Satisfai Health. This partnership will enhance the capabilities of Certai, an AI-powered assistive scoring software specifically designed for ulcerative colitis
Novotech, a global full-service clinical contract research organisation (CRO), has been awarded the 2024 Global Company of the Year Award by Frost & Sullivan. This award recognises the company’s ability to drive innovation in clinical development, offer advanced technological solutions,
